Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA
November 15th, 2021
Tag: Cell therapy
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1st, 2019
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8th, 2019
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18th, 2018
APDN’s CRO/CMO milestones in research/mfg of Linear DNA
August 3rd, 2018